Fig. 4From: Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinomaIn vitro anti-tumor activity of different formulations: a cell viability of Huh-7 cells after treated with different formulations; b induction of apoptosis in Huh-7 cells treated with various formulations tested by flow cytometer, c the statistical results of Huh-7 cell apoptosis rate (n = 3; **p < 0.01)Back to article page